Kingfish HY22: NPAT down 34.5% as investment returns normalise from a +388%...

What changed

Revenue fell 33.9% to NZ$63.2m and net profit after tax fell 34.5% to NZ$56.9m, cycling a very strong HY21 base in which revenue had grown 364% and NPAT 388%. Profit before tax tracked NPAT almost exactly (tax is immaterial at an effective rate of ~0.016%), so the decline is a pure operating-result read rather than a tax artefact. Operating cash flow turned slightly positive at NZ$1.1m from an outflow of NZ$0.2m, and cash on the balance sheet rose to NZ$20.7m from NZ$8.5m. Total equity grew 40.7% to NZ$594.4m while total liabilities fell 54% to NZ$2.7m, consistent with the investment-company structure. The interim dividend was lifted 6.1% to 3.67 cents per share.

What matters

• Earnings base reset, not a franchise deterioration. NPAT of NZ$56.9m is still well above the NZ$1.7m reported in the FY20 comparative implied by the anchor disclosures; the 34.5% drop reflects mean reversion from an exceptional HY21 rather than a step-down in underlying capability.
• ROE compression is the cleanest read. With equity up 40.7% and earnings down 34.5%, ROE fell from 17.9% to 11.2%. That is the tension in the result: a much larger capital base is now working harder for a materially smaller return this half.
• Dividend policy is diverging from earnings. DPS rose 6.1% into a 34.5% earnings decline, taking the payout ratio versus NPAT from ~9.9% to ~20.2%. This is still comfortably covered, but the direction of travel matters if returns continue to normalise.

Expectations

No quantified targets, forward-work measures, or guidance were disclosed. Against FY21 shape, HY21 contributed 61.3% of full-year revenue and 60.9% of full-year NPAT, so the prior year was first-half weighted; that pattern is not a reliable guide for a portfolio whose returns are market-driven. Annualising HY22 revenue gives NZ$126.4m versus FY21 at NZ$156.0m, so the current run-rate sits roughly 19% below the FY21 scale. The release does not support a view on whether the second half will extend or reverse this moderation.

Quality of result

For an investment vehicle, the revenue line is dominated by fair-value movements and dividend income rather than trading activity, so durability is intrinsically market-dependent. Two points argue the reported result is clean: tax is negligible in both periods so there is no NPAT distortion, and no non-recurring items or non-GAAP adjustments were disclosed. Cash conversion is weak in absolute terms (OCF of NZ$1.1m against NPAT of NZ$56.9m), but that is structural for an LIC whose profit is largely unrealised; it is not a working-capital warning. Balance-sheet support for the result is minimal – liabilities are only NZ$2.7m – so there is no leverage flattery to strip out.

Unresolved

• What portion of the NZ$56.9m result is realised versus unrealised portfolio revaluation, and how sensitive is the reported figure to end-of-period marks?
• What drove the 40.7% rise in equity – retained earnings alone cannot explain it, suggesting a capital raise or DRP activity that is not detailed in the extracted excerpts.
• Portfolio composition, concentration, and benchmark-relative performance are not disclosed here, so the read on manager alpha versus market beta is unavailable.
• How sustainable is the higher DPS if ROE stays at ~11% rather than recovering toward the ~18% prior level?

This briefing cannot assess investment portfolio composition, benchmark-relative performance, realised-versus-unrealised gain split, or the source of the equity increase.

Key metrics

Analytical metrics

This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.